Reported Mar 15, 2017 · Terminated
Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc,…
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · 1718 Northrock Ct · Rockford, IL · 61103-1201
Is this the product you have?
- Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10)
- Manufactured byMylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20
- Lot codes and dates
Batch #3083289Exp. Date 12/2018
- Amount recalled
- 58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each)
Where it was sold
- Nationwide
Why it was recalled
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Institutional, Inc. (d.b.a. UDL… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.